Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:benzoxazine
go back to main search page
Accession:CHEBI:46969 term browser browse the term
Synonyms:related_synonym: benzoxazines



show annotations for term's descendants           Sort by:
 
Benoxacor term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abca2 ATP binding cassette subfamily A member 2 increases expression ISO benoxacor results in increased expression of ABCA2 mRNA CTD PMID:34850242 NCBI chr 3:8,244,515...8,264,545
Ensembl chr 3:8,244,639...8,264,537
JBrowse link
G Abhd6 abhydrolase domain containing 6, acylglycerol lipase increases expression ISO benoxacor results in increased expression of ABHD6 mRNA CTD PMID:34850242 NCBI chr15:16,859,740...16,907,094
Ensembl chr15:16,859,738...16,906,985
JBrowse link
G Ablim1 actin-binding LIM protein 1 decreases expression ISO benoxacor results in decreased expression of ABLIM1 mRNA CTD PMID:34850242 NCBI chr 1:256,084,293...256,372,075
Ensembl chr 1:256,084,297...256,371,969
JBrowse link
G Acy3 aminoacylase 3 increases expression ISO benoxacor results in increased expression of ACY3 mRNA CTD PMID:34850242 NCBI chr 1:201,279,751...201,285,803
Ensembl chr 1:201,279,851...201,283,175
JBrowse link
G Adhfe1 alcohol dehydrogenase, iron containing, 1 decreases expression ISO benoxacor results in decreased expression of ADHFE1 mRNA CTD PMID:34850242 NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
JBrowse link
G Agxt alanine--glyoxylate and serine--pyruvate aminotransferase decreases expression ISO benoxacor results in decreased expression of AGXT mRNA CTD PMID:34850242 NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
JBrowse link
G Amdhd1 amidohydrolase domain containing 1 increases expression ISO benoxacor results in increased expression of AMDHD1 mRNA CTD PMID:34850242 NCBI chr 7:28,043,923...28,059,156
Ensembl chr 7:28,043,716...28,059,156
JBrowse link
G Anapc2 anaphase promoting complex subunit 2 increases expression ISO benoxacor results in increased expression of ANAPC2 mRNA CTD PMID:34850242 NCBI chr 3:8,086,434...8,098,182
Ensembl chr 3:8,086,462...8,098,178
JBrowse link
G Apoc1 apolipoprotein C1 increases expression ISO benoxacor results in increased expression of APOC1 mRNA CTD PMID:34850242 NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
JBrowse link
G Atp2b4 ATPase plasma membrane Ca2+ transporting 4 increases expression ISO benoxacor results in increased expression of ATP2B4 mRNA CTD PMID:34850242 NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246
JBrowse link
G Banp Btg3 associated nuclear protein decreases expression ISO benoxacor results in decreased expression of BANP mRNA CTD PMID:34850242 NCBI chr19:50,007,710...50,082,742
Ensembl chr19:50,007,881...50,082,738
JBrowse link
G Bcorl1 BCL6 co-repressor-like 1 increases expression ISO benoxacor results in increased expression of BCORL1 mRNA CTD PMID:34850242 NCBI chr  X:127,516,504...127,584,529
Ensembl chr  X:127,537,538...127,584,087
JBrowse link
G Calr calreticulin decreases expression ISO benoxacor results in decreased expression of CALR mRNA CTD PMID:34850242 NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
JBrowse link
G Cbs cystathionine beta synthase decreases expression ISO benoxacor results in decreased expression of CBS mRNA CTD PMID:34850242 NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
JBrowse link
G Ccdc62 coiled-coil domain containing 62 increases expression ISO benoxacor results in increased expression of CCDC62 mRNA CTD PMID:34850242 NCBI chr12:32,623,170...32,659,912
Ensembl chr12:32,623,170...32,660,017
JBrowse link
G Cers6 ceramide synthase 6 decreases expression ISO benoxacor results in decreased expression of CERS6 mRNA CTD PMID:34850242 NCBI chr 3:53,630,636...53,879,692
Ensembl chr 3:53,630,959...53,876,848
JBrowse link
G Cgn cingulin decreases expression ISO benoxacor results in decreased expression of CGN mRNA CTD PMID:34850242 NCBI chr 2:182,308,389...182,335,747
Ensembl chr 2:182,308,714...182,334,645
JBrowse link
G Cox7a2 cytochrome c oxidase subunit 7A2 increases expression ISO benoxacor results in increased expression of COX7A2 mRNA CTD PMID:34850242 NCBI chr 8:80,716,824...80,720,922
Ensembl chr14:51,301,168...51,301,633
JBrowse link
G Cpn1 carboxypeptidase N subunit 1 decreases expression ISO benoxacor results in decreased expression of CPN1 mRNA CTD PMID:34850242 NCBI chr 1:242,844,575...242,873,465
Ensembl chr 1:242,844,212...242,873,465
JBrowse link
G Crbn cereblon increases expression ISO benoxacor results in increased expression of CRBN mRNA CTD PMID:34850242 NCBI chr 4:139,701,154...139,719,949
Ensembl chr 4:139,701,094...139,719,938
JBrowse link
G Ctsl cathepsin L decreases expression ISO benoxacor results in decreased expression of CTSL mRNA CTD PMID:34850242 NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
JBrowse link
G Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 decreases expression ISO benoxacor results in decreased expression of CYP26A1 mRNA CTD PMID:34850242 NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 decreases expression ISO benoxacor results in decreased expression of CYP3A13 mRNA CTD PMID:34850242 NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 increases expression ISO benoxacor results in increased expression of CYP7A1 mRNA CTD PMID:34850242 NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
JBrowse link
G Ddost dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit decreases expression ISO benoxacor results in decreased expression of DDOST mRNA CTD PMID:34850242 NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
JBrowse link
G Dhx37 DEAH-box helicase 37 increases expression ISO benoxacor results in increased expression of DHX37 mRNA CTD PMID:34850242 NCBI chr12:31,194,782...31,214,890
Ensembl chr12:31,194,859...31,216,802
JBrowse link
G Dlgap4 DLG associated protein 4 increases expression ISO benoxacor results in increased expression of DLGAP4 mRNA CTD PMID:34850242 NCBI chr 3:145,124,189...145,271,791
Ensembl chr 3:145,175,479...145,270,490
JBrowse link
G Dnajc12 DnaJ heat shock protein family (Hsp40) member C12 decreases expression ISO benoxacor results in decreased expression of DNAJC12 mRNA CTD PMID:34850242 NCBI chr20:25,246,744...25,267,508
Ensembl chr20:25,223,144...25,267,521
JBrowse link
G Dxo decapping exoribonuclease decreases expression ISO benoxacor results in decreased expression of DXO mRNA CTD PMID:34850242 NCBI chr20:3,993,322...3,995,484
Ensembl chr20:3,993,327...3,995,494
JBrowse link
G E2f5 E2F transcription factor 5 increases expression ISO benoxacor results in increased expression of E2F5 mRNA CTD PMID:34850242 NCBI chr 2:86,997,331...87,012,901
Ensembl chr 2:86,997,332...87,012,990
JBrowse link
G Eaf2 ELL associated factor 2 decreases expression ISO benoxacor results in decreased expression of EAF2 mRNA CTD PMID:34850242 NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
JBrowse link
G Eef1g eukaryotic translation elongation factor 1 gamma decreases expression ISO benoxacor results in decreased expression of EEF1G mRNA CTD PMID:34850242 NCBI chr 1:205,860,713...205,871,319
Ensembl chr 1:205,860,698...205,872,382
JBrowse link
G Eef2k eukaryotic elongation factor-2 kinase increases expression ISO benoxacor results in increased expression of EEF2K mRNA CTD PMID:34850242 NCBI chr 1:175,393,119...175,454,452
Ensembl chr 1:175,393,154...175,455,164
JBrowse link
G Etf1 eukaryotic translation termination factor 1 decreases expression ISO benoxacor results in decreased expression of ETF1 mRNA CTD PMID:34850242 NCBI chr18:26,502,413...26,530,753
Ensembl chr18:26,504,080...26,530,810
JBrowse link
G Fam124a family with sequence similarity 124 member A decreases expression ISO benoxacor results in decreased expression of FAM124A mRNA CTD PMID:34850242 NCBI chr15:36,799,836...36,855,062
Ensembl chr15:36,799,877...36,853,683
JBrowse link
G Fastkd3 FAST kinase domains 3 increases expression ISO benoxacor results in increased expression of FASTKD3 mRNA CTD PMID:34850242 NCBI chr 1:34,858,342...34,866,988
Ensembl chr 1:34,858,219...34,866,973
JBrowse link
G Fbxo33 F-box protein 33 increases expression ISO benoxacor results in increased expression of FBXO33 mRNA CTD PMID:34850242 NCBI chr 6:76,900,619...76,934,232
Ensembl chr 6:76,900,631...76,932,669
JBrowse link
G Fmo2 flavin containing dimethylaniline monoxygenase 2 increases expression ISO benoxacor results in increased expression of FMO2 mRNA CTD PMID:34850242 NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
JBrowse link
G Foxa2 forkhead box A2 increases expression ISO benoxacor results in increased expression of FOXA2 mRNA CTD PMID:34850242 NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
JBrowse link
G Fto FTO, alpha-ketoglutarate dependent dioxygenase decreases expression ISO benoxacor results in decreased expression of FTO mRNA CTD PMID:34850242 NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
JBrowse link
G G3bp2 G3BP stress granule assembly factor 2 decreases expression ISO benoxacor results in decreased expression of G3BP2 mRNA CTD PMID:34850242 NCBI chr14:15,932,356...16,020,555
Ensembl chr14:15,987,417...16,020,548
JBrowse link
G Gabbr1 gamma-aminobutyric acid type B receptor subunit 1 increases expression ISO benoxacor results in increased expression of GABBR1 mRNA CTD PMID:34850242 NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994
JBrowse link
G Gan gigaxonin decreases expression ISO benoxacor results in decreased expression of GAN mRNA CTD PMID:34850242 NCBI chr19:45,207,864...45,258,831
Ensembl chr19:45,207,184...45,254,107
JBrowse link
G Gas2 growth arrest-specific 2 increases expression ISO benoxacor results in increased expression of GAS2 mRNA CTD PMID:34850242 NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
JBrowse link
G Glo1 glyoxalase 1 decreases expression ISO benoxacor results in decreased expression of GLO1 mRNA CTD PMID:34850242 NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
JBrowse link
G Gnpat glyceronephosphate O-acyltransferase increases expression ISO benoxacor results in increased expression of GNPAT mRNA CTD PMID:34850242 NCBI chr19:52,822,326...52,848,872
Ensembl chr19:52,822,319...52,852,361
JBrowse link
G Gon4l gon-4 like increases expression ISO benoxacor results in increased expression of GON4L mRNA CTD PMID:34850242 NCBI chr 2:174,233,461...174,306,636
Ensembl chr 2:174,233,461...174,306,634
JBrowse link
G Gpatch2l G patch domain containing 2-like increases expression ISO benoxacor results in increased expression of GPATCH2L mRNA CTD PMID:34850242 NCBI chr 6:105,883,383...105,935,644
Ensembl chr 6:105,883,460...105,934,888
JBrowse link
G Gpr107 G protein-coupled receptor 107 increases expression ISO benoxacor results in increased expression of GPR107 mRNA CTD PMID:34850242 NCBI chr 3:14,431,704...14,497,623
Ensembl chr 3:14,434,723...14,495,958
JBrowse link
G Grb2 growth factor receptor bound protein 2 decreases expression ISO benoxacor results in decreased expression of GRB2 mRNA CTD PMID:34850242 NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
JBrowse link
G Gtf2ird1 GTF2I repeat domain containing 1 decreases expression ISO benoxacor results in decreased expression of GTF2IRD1 mRNA CTD PMID:34850242 NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040
JBrowse link
G Gucd1 guanylyl cyclase domain containing 1 decreases expression ISO benoxacor results in decreased expression of GUCD1 mRNA CTD PMID:34850242 NCBI chr20:13,145,617...13,156,330
Ensembl chr20:13,146,076...13,156,328
JBrowse link
G Hectd2 HECT domain E3 ubiquitin protein ligase 2 increases expression ISO benoxacor results in increased expression of HECTD2 mRNA CTD PMID:34850242 NCBI chr 1:234,274,967...234,345,598
Ensembl chr 1:234,275,705...234,343,487
JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B increases expression ISO benoxacor results in increased expression of HSPA1B mRNA CTD PMID:34850242 NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240
JBrowse link
G Htt huntingtin decreases expression ISO benoxacor results in decreased expression of HTT mRNA CTD PMID:34850242 NCBI chr14:75,845,836...75,996,094
Ensembl chr14:75,845,836...75,995,070
JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 decreases expression ISO benoxacor results in decreased expression of IFIT3 mRNA CTD PMID:34850242 NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
JBrowse link
G Ilkap ILK associated serine/threonine phosphatase increases expression ISO benoxacor results in increased expression of ILKAP mRNA CTD PMID:34850242 NCBI chr 9:91,966,440...91,988,791
Ensembl chr 9:91,966,441...91,988,892
JBrowse link
G Ilvbl ilvB acetolactate synthase like increases expression ISO benoxacor results in increased expression of ILVBL mRNA CTD PMID:34850242 NCBI chr 7:11,039,870...11,049,924
Ensembl chr 7:11,039,871...11,049,924
JBrowse link
G Insig2 insulin induced gene 2 decreases expression ISO benoxacor results in decreased expression of INSIG2 mRNA CTD PMID:34850242 NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
JBrowse link
G Irgm immunity-related GTPase M decreases expression ISO benoxacor results in decreased expression of IRGM1 mRNA CTD PMID:34850242 NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
JBrowse link
G Jak1 Janus kinase 1 decreases expression ISO benoxacor results in decreased expression of JAK1 mRNA CTD PMID:34850242 NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
JBrowse link
G Jpx JPX transcript, XIST activator decreases expression ISO benoxacor results in decreased expression of JPX mRNA CTD PMID:34850242 NCBI chr  X:68,511,491...68,665,132 JBrowse link
G Kdsr 3-ketodihydrosphingosine reductase increases expression ISO benoxacor results in increased expression of KDSR mRNA CTD PMID:34850242 NCBI chr13:22,862,117...22,894,118
Ensembl chr13:22,862,117...22,894,108
JBrowse link
G Kyat3 kynurenine aminotransferase 3 decreases expression ISO benoxacor results in decreased expression of KYAT3 mRNA CTD PMID:34850242 NCBI chr 2:231,701,881...231,747,462
Ensembl chr 2:231,701,963...231,747,227
JBrowse link
G Lifr LIF receptor subunit alpha decreases expression ISO benoxacor results in decreased expression of LIFR mRNA CTD PMID:34850242 NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699
JBrowse link
G Lin7a lin-7 homolog A, crumbs cell polarity complex component decreases expression ISO benoxacor results in decreased expression of LIN7A mRNA CTD PMID:34850242 NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
JBrowse link
G Llph LLP homolog, long-term synaptic facilitation factor decreases expression ISO benoxacor results in decreased expression of LLPH mRNA CTD PMID:34850242 NCBI chr 7:55,735,317...55,740,341
Ensembl chr 7:55,735,400...55,740,339
JBrowse link
G Lmbr1l limb development membrane protein 1-like decreases expression ISO benoxacor results in decreased expression of LMBR1L mRNA CTD PMID:34850242 NCBI chr 7:130,061,136...130,078,101
Ensembl chr 7:130,061,136...130,076,381
JBrowse link
G Lpin1 lipin 1 increases expression ISO benoxacor results in increased expression of LPIN1 mRNA CTD PMID:34850242 NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
JBrowse link
G Lpl lipoprotein lipase decreases expression ISO benoxacor results in decreased expression of LPL mRNA CTD PMID:34850242 NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
JBrowse link
G Madd MAP-kinase activating death domain increases expression ISO benoxacor results in increased expression of MADD mRNA CTD PMID:34850242 NCBI chr 3:77,114,330...77,157,865
Ensembl chr 3:77,114,314...77,157,701
JBrowse link
G Maged1 MAGE family member D1 decreases expression ISO benoxacor results in decreased expression of MAGED1 mRNA CTD PMID:34850242 NCBI chr  X:59,422,715...59,429,381
Ensembl chr  X:59,422,717...59,429,364
JBrowse link
G Man1b1 mannosidase, alpha, class 1B, member 1 increases expression ISO benoxacor results in increased expression of MAN1B1 mRNA CTD PMID:34850242 NCBI chr 3:8,143,877...8,165,007
Ensembl chr 3:8,143,381...8,165,006
JBrowse link
G Manea mannosidase, endo-alpha increases expression ISO benoxacor results in increased expression of MANEA mRNA CTD PMID:34850242 NCBI chr 5:40,196,373...40,218,534
Ensembl chr 5:40,196,396...40,218,459
JBrowse link
G Mat1a methionine adenosyltransferase 1A increases expression ISO benoxacor results in increased expression of MAT1A mRNA CTD PMID:34850242 NCBI chr16:16,983,084...17,001,284
Ensembl chr16:16,983,022...17,001,274
JBrowse link
G Mcee methylmalonyl CoA epimerase increases expression ISO benoxacor results in increased expression of MCEE mRNA CTD PMID:34850242 NCBI chr 1:117,964,576...117,987,779
Ensembl chr 1:117,964,576...117,988,484
JBrowse link
G Miga2 mitoguardin 2 increases expression ISO benoxacor results in increased expression of MIGA2 mRNA CTD PMID:34850242 NCBI chr 3:13,636,144...13,658,896
Ensembl chr 3:13,636,238...13,658,896
JBrowse link
G Mmab metabolism of cobalamin associated B decreases expression ISO benoxacor results in decreased expression of MMAB mRNA CTD PMID:34850242 NCBI chr12:42,159,109...42,172,496
Ensembl chr12:42,159,089...42,172,490
JBrowse link
G Mme membrane metallo-endopeptidase increases expression ISO benoxacor results in increased expression of MME mRNA CTD PMID:34850242 NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
JBrowse link
G Mmut methylmalonyl-CoA mutase decreases expression ISO benoxacor results in decreased expression of MMUT mRNA CTD PMID:34850242 NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046
JBrowse link
G Mocs1 molybdenum cofactor synthesis 1 increases expression ISO benoxacor results in increased expression of MOCS1 mRNA CTD PMID:34850242 NCBI chr 9:11,547,533...11,573,935
Ensembl chr 9:11,547,531...11,567,790
JBrowse link
G Mroh2a maestro heat-like repeat family member 2A increases expression ISO benoxacor results in increased expression of MROH2A mRNA CTD PMID:34850242 NCBI chr 9:88,814,515...88,862,346
Ensembl chr 9:88,814,197...88,852,607
JBrowse link
G Mylk myosin light chain kinase increases expression ISO benoxacor results in increased expression of MYLK mRNA CTD PMID:34850242 NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
JBrowse link
G Nasp nuclear autoantigenic sperm protein increases expression ISO benoxacor results in increased expression of NASP mRNA CTD PMID:34850242 NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
JBrowse link
G Nphp3 nephrocystin 3 decreases expression ISO benoxacor results in decreased expression of NPHP3 mRNA CTD PMID:34850242 NCBI chr 8:104,621,908...104,662,383
Ensembl chr 8:104,621,864...104,662,383
JBrowse link
G Npm1 nucleophosmin 1 decreases expression ISO benoxacor results in decreased expression of NPM1 mRNA CTD PMID:34850242 NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 decreases expression ISO benoxacor results in decreased expression of NR3C2 mRNA CTD PMID:34850242 NCBI chr19:30,715,648...31,059,885
Ensembl chr19:30,715,648...31,059,885
JBrowse link
G Nrdc nardilysin convertase decreases expression ISO benoxacor results in decreased expression of NRD1 mRNA CTD PMID:34850242 NCBI chr 5:123,755,807...123,818,910
Ensembl chr 5:123,755,806...123,818,595
JBrowse link
G Nsd3 nuclear receptor binding SET domain protein 3 decreases expression ISO benoxacor results in decreased expression of NSD3 mRNA CTD PMID:34850242 NCBI chr16:66,354,030...66,466,202
Ensembl chr16:66,358,973...66,465,423
JBrowse link
G Nt5dc3 5'-nucleotidase domain containing 3 increases expression ISO benoxacor results in increased expression of NT5DC3 mRNA CTD PMID:34850242 NCBI chr 7:21,190,554...21,247,374
Ensembl chr 7:21,190,554...21,247,374
JBrowse link
G Nucb2 nucleobindin 2 decreases expression ISO benoxacor results in decreased expression of NUCB2 mRNA CTD PMID:34850242 NCBI chr 1:170,750,830...170,787,356
Ensembl chr 1:170,750,877...170,787,353
JBrowse link
G Orm1 orosomucoid 1 decreases expression ISO benoxacor results in decreased expression of ORM1 mRNA CTD PMID:34850242 NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
JBrowse link
G Os9 OS9, endoplasmic reticulum lectin decreases expression ISO benoxacor results in decreased expression of OS9 mRNA CTD PMID:34850242 NCBI chr 7:62,915,498...62,957,591
Ensembl chr 7:62,915,515...62,943,745
JBrowse link
G Phospho1 phosphoethanolamine/phosphocholine phosphatase 1 decreases expression ISO benoxacor results in decreased expression of PHOSPHO1 mRNA CTD PMID:34850242 NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342
JBrowse link
G Pigo phosphatidylinositol glycan anchor biosynthesis, class O increases expression ISO benoxacor results in increased expression of PIGO mRNA CTD PMID:34850242 NCBI chr 5:57,244,721...57,256,252
Ensembl chr 5:57,245,166...57,254,146
JBrowse link
G Pitpnm1 phosphatidylinositol transfer protein, membrane-associated 1 increases expression ISO benoxacor results in increased expression of PITPNM1 mRNA CTD PMID:34850242 NCBI chr 1:201,394,099...201,407,523
Ensembl chr 1:201,394,149...201,407,522
JBrowse link
G Plcb3 phospholipase C beta 3 increases expression ISO benoxacor results in increased expression of PLCB3 mRNA CTD PMID:34850242 NCBI chr 1:204,143,257...204,160,384
Ensembl chr 1:204,144,956...204,160,228
JBrowse link
G Plce1 phospholipase C, epsilon 1 decreases expression ISO benoxacor results in decreased expression of PLCE1 mRNA CTD PMID:34850242 NCBI chr 1:236,243,445...236,552,571
Ensembl chr 1:236,244,683...236,551,438
JBrowse link
G Pm20d1 peptidase M20 domain containing 1 decreases expression ISO benoxacor results in decreased expression of PM20D1 mRNA CTD PMID:34850242 NCBI chr13:43,237,954...43,259,999
Ensembl chr13:43,237,971...43,259,999
JBrowse link
G Pmvk phosphomevalonate kinase decreases expression ISO benoxacor results in decreased expression of PMVK mRNA CTD PMID:34850242 NCBI chr 2:174,876,586...174,886,365
Ensembl chr 2:174,876,657...174,886,364
JBrowse link
G Pnpla7 patatin-like phospholipase domain containing 7 decreases expression ISO benoxacor results in decreased expression of PNPLA7 mRNA CTD PMID:34850242 NCBI chr 3:7,782,572...7,861,504
Ensembl chr 3:7,782,572...7,861,497
JBrowse link
G Pomk protein-O-mannose kinase decreases expression ISO benoxacor results in decreased expression of POMK mRNA CTD PMID:34850242 NCBI chr16:66,085,569...66,101,360
Ensembl chr16:66,088,000...66,098,388
JBrowse link
G Prmt3 protein arginine methyltransferase 3 decreases expression ISO benoxacor results in decreased expression of PRMT3 mRNA CTD PMID:34850242 NCBI chr 1:99,492,712...99,581,774
Ensembl chr 1:99,492,724...99,579,435
JBrowse link
G Pros1 protein S decreases expression ISO benoxacor results in decreased expression of PROS1 mRNA CTD PMID:34850242 NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
JBrowse link
G Psmd2 proteasome 26S subunit ubiquitin receptor, non-ATPase 2 decreases expression ISO benoxacor results in decreased expression of PSMD2 mRNA CTD PMID:34850242 NCBI chr11:80,248,364...80,258,991
Ensembl chr11:80,248,364...80,259,043
JBrowse link
G Psmf1 proteasome inhibitor subunit 1 increases expression ISO benoxacor results in increased expression of PSMF1 mRNA CTD PMID:34850242 NCBI chr 3:140,235,371...140,260,546
Ensembl chr 3:140,235,373...140,260,546
JBrowse link
G Ptk2b protein tyrosine kinase 2 beta increases expression ISO benoxacor results in increased expression of PTK2B mRNA CTD PMID:34850242 NCBI chr15:40,360,722...40,481,235
Ensembl chr15:40,360,723...40,481,282
JBrowse link
G Ptpra protein tyrosine phosphatase, receptor type, A decreases expression ISO benoxacor results in decreased expression of PTPRA mRNA CTD PMID:34850242 NCBI chr 3:117,650,146...117,759,744
Ensembl chr 3:117,650,183...117,759,728
JBrowse link
G Rabl3 RAB, member of RAS oncogene family-like 3 decreases expression ISO benoxacor results in decreased expression of RABL3 mRNA CTD PMID:34850242 NCBI chr11:63,153,281...63,182,240
Ensembl chr11:63,152,792...63,182,671
JBrowse link
G Rbpms RNA binding protein, mRNA processing factor decreases expression ISO benoxacor results in decreased expression of RBPMS mRNA CTD PMID:34850242 NCBI chr16:58,239,370...58,395,424
Ensembl chr16:58,239,474...58,395,426
JBrowse link
G Rpp40 ribonuclease P/MRP subunit p40 increases expression ISO benoxacor results in increased expression of RPP40 mRNA CTD PMID:34850242 NCBI chr17:28,947,730...28,956,790
Ensembl chr17:28,947,734...28,956,788
JBrowse link
G Samm50 SAMM50 sorting and assembly machinery component increases expression ISO benoxacor results in increased expression of SAMM50 mRNA CTD PMID:34850242 NCBI chr 7:115,317,472...115,341,682
Ensembl chr 7:115,317,404...115,341,682
JBrowse link
G Sap30bp SAP30 binding protein increases expression ISO benoxacor results in increased expression of SAP30BP mRNA CTD PMID:34850242 NCBI chr10:101,165,777...101,198,503
Ensembl chr10:101,165,856...101,198,502
JBrowse link
G Scap SREBF chaperone decreases expression ISO benoxacor results in decreased expression of SCAP mRNA CTD PMID:34850242 NCBI chr 8:110,306,031...110,360,677
Ensembl chr 8:110,306,031...110,360,666
JBrowse link
G Sdc4 syndecan 4 decreases expression ISO benoxacor results in decreased expression of SDC4 mRNA CTD PMID:34850242 NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
JBrowse link
G Sdf2l1 stromal cell-derived factor 2-like 1 decreases expression ISO benoxacor results in decreased expression of SDF2L1 mRNA CTD PMID:34850242 NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902
JBrowse link
G Sec24d SEC24 homolog D, COPII coat complex component decreases expression ISO benoxacor results in decreased expression of SEC24D mRNA CTD PMID:34850242 NCBI chr 2:211,418,557...211,526,588
Ensembl chr 2:211,418,623...211,526,587
JBrowse link
G Septin11 septin 11 decreases expression ISO benoxacor results in decreased expression of SEPTIN11 mRNA CTD PMID:34850242 NCBI chr14:14,844,759...14,990,856
Ensembl chr14:14,844,580...14,990,853
JBrowse link
G Slc17a1 solute carrier family 17 member 1 decreases expression ISO benoxacor results in decreased expression of SLC17A1 mRNA CTD PMID:34850242 NCBI chr17:41,219,461...41,255,199
Ensembl chr17:41,222,049...41,253,304
JBrowse link
G Slc22a15 solute carrier family 22, member 15 increases expression ISO benoxacor results in increased expression of SLC22A15 mRNA CTD PMID:34850242 NCBI chr 2:189,298,832...189,359,902
Ensembl chr 2:189,298,832...189,358,792
JBrowse link
G Slc22a23 solute carrier family 22, member 23 increases expression ISO benoxacor results in increased expression of SLC22A23 mRNA CTD PMID:34850242 NCBI chr17:30,544,106...30,709,790
Ensembl chr17:30,544,106...30,709,790
JBrowse link
G Slc25a48 solute carrier family 25, member 48 increases expression ISO benoxacor results in increased expression of SLC25A48 mRNA CTD PMID:34850242 NCBI chr17:8,119,964...8,161,293
Ensembl chr17:8,121,175...8,160,748
JBrowse link
G Slc26a1 solute carrier family 26 member 1 increases expression ISO benoxacor results in increased expression of SLC26A1 mRNA CTD PMID:34850242 NCBI chr14:1,040,565...1,045,851
Ensembl chr14:1,040,243...1,045,849
JBrowse link
G Slco2a1 solute carrier organic anion transporter family, member 2a1 decreases expression ISO benoxacor results in decreased expression of SLCO2A1 mRNA CTD PMID:34850242 NCBI chr 8:103,588,916...103,672,546
Ensembl chr 8:103,588,916...103,672,546
JBrowse link
G Smagp small cell adhesion glycoprotein decreases expression ISO benoxacor results in decreased expression of SMAGP mRNA CTD PMID:34850242 NCBI chr 7:131,720,260...131,738,711
Ensembl chr 7:131,718,740...131,738,691
JBrowse link
G Strap serine/threonine kinase receptor associated protein decreases expression ISO benoxacor results in decreased expression of STRAP mRNA CTD PMID:34850242 NCBI chr 4:170,646,042...170,660,291
Ensembl chr 4:170,646,001...170,660,828
JBrowse link
G Sugt1 SGT1 homolog, MIS12 kinetochore complex assembly cochaperone increases expression ISO benoxacor results in increased expression of SUGT1 mRNA CTD PMID:34850242 NCBI chr15:54,991,419...55,032,244
Ensembl chr15:54,990,672...55,069,150
JBrowse link
G Syvn1 synoviolin 1 decreases expression ISO benoxacor results in decreased expression of SYVN1 mRNA CTD PMID:34850242 NCBI chr 1:203,339,235...203,346,137
Ensembl chr 1:203,339,619...203,346,152
JBrowse link
G Taf11 TATA-box binding protein associated factor 11 increases expression ISO benoxacor results in increased expression of TAF11 mRNA CTD PMID:34850242 NCBI chr20:5,955,774...5,963,593
Ensembl chr20:5,955,777...5,961,905
JBrowse link
G Taf5 TATA-box binding protein associated factor 5 decreases expression ISO benoxacor results in decreased expression of TAF5 mRNA CTD PMID:34850242 NCBI chr 1:245,958,428...245,973,914
Ensembl chr 1:245,958,428...245,973,914
JBrowse link
G Tapt1 transmembrane anterior posterior transformation 1 decreases expression ISO benoxacor results in decreased expression of TAPT1 mRNA CTD PMID:34850242 NCBI chr14:66,873,467...66,919,737
Ensembl chr14:66,873,459...66,919,741
JBrowse link
G Tfe3 transcription factor binding to IGHM enhancer 3 decreases expression ISO benoxacor results in decreased expression of TFE3 mRNA CTD PMID:34850242 NCBI chr  X:14,729,547...14,742,830
Ensembl chr  X:14,729,550...14,742,571
JBrowse link
G Tifa TRAF-interacting protein with forkhead-associated domain decreases expression ISO benoxacor results in decreased expression of TIFA mRNA CTD PMID:34850242 NCBI chr 2:216,257,926...216,267,635
Ensembl chr 2:216,234,774...216,267,841
JBrowse link
G Tmem267 transmembrane protein 267 increases expression ISO benoxacor results in increased expression of TMEM267 mRNA CTD PMID:34850242 NCBI chr 2:51,580,210...51,588,937
Ensembl chr 2:51,581,252...51,587,636
JBrowse link
G Tmem50a transmembrane protein 50A decreases expression ISO benoxacor results in decreased expression of TMEM50A mRNA CTD PMID:34850242 NCBI chr 5:147,123,670...147,138,859
Ensembl chr 5:147,123,688...147,138,849
JBrowse link
G Tmtc2 transmembrane O-mannosyltransferase targeting cadherins 2 increases expression ISO benoxacor results in increased expression of TMTC2 mRNA CTD PMID:34850242 NCBI chr 7:40,392,377...40,806,685
Ensembl chr 7:40,394,220...40,807,298
JBrowse link
G Tns1 tensin 1 increases expression ISO benoxacor results in increased expression of TNS1 mRNA CTD PMID:34850242 NCBI chr 9:75,491,886...75,702,853
Ensembl chr 9:75,495,814...75,703,225
JBrowse link
G Tsc2 TSC complex subunit 2 increases expression ISO benoxacor results in increased expression of TSC2 mRNA CTD PMID:34850242 NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
JBrowse link
G Ttc41 tetratricopeptide repeat domain 41 increases expression ISO benoxacor results in increased expression of NT5DC3 mRNA CTD PMID:34850242 NCBI chr 7:21,124,909...21,188,191
Ensembl chr 7:21,125,105...21,188,189
JBrowse link
G Tuba4a tubulin, alpha 4A decreases expression ISO benoxacor results in decreased expression of TUBA4A mRNA CTD PMID:34850242 NCBI chr 9:76,709,617...76,714,327
Ensembl chr 9:76,709,614...76,713,918
JBrowse link
G Tubgcp5 tubulin, gamma complex associated protein 5 decreases expression ISO benoxacor results in decreased expression of TUBGCP5 mRNA CTD PMID:34850242 NCBI chr 1:106,636,526...106,672,175
Ensembl chr 1:106,636,526...106,672,175
JBrowse link
G Uba1 ubiquitin-like modifier activating enzyme 1 decreases expression ISO benoxacor results in decreased expression of UBA1 mRNA CTD PMID:34850242 NCBI chr  X:1,508,700...1,530,677
Ensembl chr  X:1,508,666...1,530,636
JBrowse link
G Ulk1 unc-51 like autophagy activating kinase 1 increases expression ISO benoxacor results in increased expression of ULK1 mRNA CTD PMID:34850242 NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
JBrowse link
G Usp3 ubiquitin specific peptidase 3 increases expression ISO benoxacor results in increased expression of USP3 mRNA CTD PMID:34850242 NCBI chr 8:67,078,249...67,154,109
Ensembl chr 8:67,079,927...67,154,111
JBrowse link
G Wdr12 WD repeat domain 12 increases expression ISO benoxacor results in increased expression of WDR12 mRNA CTD PMID:34850242 NCBI chr 9:61,475,498...61,502,584
Ensembl chr 9:61,475,517...61,502,469
JBrowse link
G Xdh xanthine dehydrogenase increases expression ISO benoxacor results in increased expression of XDH mRNA CTD PMID:34850242 NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
JBrowse link
G Ythdc2 YTH domain containing 2 increases expression ISO benoxacor results in increased expression of YTHDC2 mRNA CTD PMID:34850242 NCBI chr18:37,266,559...37,331,681
Ensembl chr18:37,265,836...37,331,023
JBrowse link
G Zbtb16 zinc finger and BTB domain containing 16 decreases expression ISO benoxacor results in decreased expression of ZBTB16 mRNA CTD PMID:34850242 NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011
JBrowse link
G Zc3h13 zinc finger CCCH type containing 13 decreases expression ISO benoxacor results in decreased expression of ZC3H13 mRNA CTD PMID:34850242 NCBI chr15:50,607,335...50,671,802
Ensembl chr15:50,607,380...50,671,802
JBrowse link
G Zfp146 zinc finger protein 146 increases expression ISO benoxacor results in increased expression of ZFP146 mRNA CTD PMID:34850242 NCBI chr 1:85,409,570...85,421,884
Ensembl chr 1:85,409,373...85,436,275
JBrowse link
G Zfp36l2 zinc finger protein 36, C3H type-like 2 decreases expression ISO benoxacor results in decreased expression of ZFP36L2 mRNA CTD PMID:34850242 NCBI chr 6:10,490,032...10,494,073
Ensembl chr 6:10,490,032...10,494,064
JBrowse link
G Zfp644 zinc finger protein 644 increases expression ISO benoxacor results in increased expression of ZFP644 mRNA CTD PMID:34850242 NCBI chr14:3,105,002...3,179,955
Ensembl chr14:3,105,178...3,179,940
JBrowse link
cetilistat term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Hba-a2 hemoglobin alpha, adult chain 2 decreases expression ISO cetilistat results in decreased expression of HBA1 protein modified form CTD PMID:19461584 NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392
JBrowse link
efavirenz term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions
decreases activity
ISO efavirenz inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
efavirenz results in decreased activity of ABCB11 protein
CTD PMID:24014644 NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression
decreases secretion
ISO efavirenz results in decreased expression of ADIPOQ mRNA
efavirenz results in decreased secretion of ADIPOQ protein
CTD PMID:21619898 NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
JBrowse link
G Alb albumin affects binding ISO efavirenz binds to ALB protein CTD PMID:15814459 PMID:16336266 NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
JBrowse link
G Bcl2l11 Bcl2-like 11 increases response to substance
increases expression
ISO BCL2L11 protein results in increased susceptibility to efavirenz metabolite
efavirenz metabolite results in increased expression of BCL2L11 mRNA; efavirenz metabolite results in increased expression of BCL2L11 protein; efavirenz results in increased expression of BCL2L11 mRNA; efavirenz results in increased expression of BCL2L11 protein
CTD PMID:21958719 NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
JBrowse link
G Canx calnexin affects localization ISO efavirenz affects the localization of CANX protein CTD PMID:28940366 NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
JBrowse link
G Casp3 caspase 3 multiple interactions ISO efavirenz metabolite results in increased cleavage of and results in increased activity of CASP3 protein; efavirenz results in increased cleavage of and results in increased activity of CASP3 protein CTD PMID:21958719 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G Cat catalase multiple interactions EXP [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in decreased activity of CAT protein CTD PMID:34118364 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases secretion ISO efavirenz results in increased secretion of CCL2 protein CTD PMID:21619898 NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha decreases expression ISO efavirenz results in decreased expression of CEBPA mRNA CTD PMID:21619898 NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 affects metabolic processing
decreases activity
multiple interactions
increases metabolic processing
ISO CYP2B6 gene polymorphism affects the metabolism of efavirenz; CYP2B6 protein affects the metabolism of efavirenz
efavirenz results in decreased activity of CYP2B6 protein
[efavirenz results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion; [efavirenz results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [efavirenz results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA
CYP2B6 protein results in increased metabolism of efavirenz
CTD PMID:15622315 PMID:15769884 PMID:17041008 PMID:17559344 PMID:26599973 NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 decreases activity ISO efavirenz results in decreased activity of CYP2C19 protein CTD PMID:11225565 NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases activity
increases expression
increases activity
ISO efavirenz results in decreased activity of CYP3A4 protein
efavirenz results in increased expression of CYP3A4 mRNA
efavirenz results in increased activity of CYP3A4 protein
CTD PMID:15980690 PMID:16837568 NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO efavirenz results in increased expression of DDIT3 protein CTD PMID:28940366 NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
JBrowse link
G Dnm1l dynamin 1-like affects localization ISO efavirenz affects the localization of DNM1L protein modified form CTD PMID:28940366 NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases expression ISO efavirenz results in increased expression of EIF2AK3 protein modified form CTD PMID:28940366 NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
JBrowse link
G Fis1 fission, mitochondrial 1 increases expression ISO efavirenz results in increased expression of FIS1 mRNA CTD PMID:28940366 NCBI chr12:19,708,558...19,723,392
Ensembl chr12:19,708,558...19,723,377
JBrowse link
G Hgf hepatocyte growth factor increases secretion ISO efavirenz results in increased secretion of HGF protein CTD PMID:21619898 NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 multiple interactions ISO efavirenz promotes the reaction [VDAC1 protein binds to HSPA9 protein] CTD PMID:28940366 NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
JBrowse link
G Il6 interleukin 6 increases secretion ISO efavirenz results in increased secretion of IL6 protein CTD PMID:21619898 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases phosphorylation ISO efavirenz metabolite results in increased phosphorylation of JUN protein; efavirenz results in increased phosphorylation of JUN protein CTD PMID:21958719 NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
JBrowse link
G Lep leptin decreases expression ISO efavirenz results in decreased expression of LEP mRNA CTD PMID:21619898 NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
JBrowse link
G Lonp1 lon peptidase 1, mitochondrial multiple interactions
increases expression
increases response to substance
ISO efavirenz results in increased expression of and affects the localization of LONP1 protein; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [efavirenz results in increased expression of LONP1 mRNA]
LONP1 protein results in increased susceptibility to efavirenz
CTD PMID:28940366 NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
JBrowse link
G Lpl lipoprotein lipase decreases expression ISO efavirenz results in decreased expression of LPL mRNA CTD PMID:21619898 NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 increases phosphorylation ISO efavirenz metabolite results in increased phosphorylation of MAP3K5 protein; efavirenz results in increased phosphorylation of MAP3K5 protein CTD PMID:21958719 NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions
increases phosphorylation
ISO Acetylcysteine inhibits the reaction [efavirenz metabolite results in increased phosphorylation of MAPK8 protein]; Acetylcysteine inhibits the reaction [efavirenz results in increased phosphorylation of MAPK8 protein]
efavirenz metabolite results in increased phosphorylation of MAPK8 protein; efavirenz results in increased phosphorylation of MAPK8 protein
CTD PMID:21958719 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
JBrowse link
G Mfn2 mitofusin 2 increases expression ISO efavirenz results in increased expression of MFN2 mRNA CTD PMID:28940366 NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
JBrowse link
G Mpo myeloperoxidase multiple interactions EXP [efavirenz co-treated with Lamivudine co-treated with Tenofovir] promotes the reaction [[isoniazid, pyrazinamide, rifampin drug combination co-treated with Ethambutol] results in increased activity of MPO protein]; [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of MPO protein CTD PMID:34118364 NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity EXP efavirenz results in increased activity of NR1I2 protein CTD PMID:27732639 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions
increases activity
ISO
EXP
[efavirenz results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [efavirenz results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA CTD PMID:17041008 PMID:27732639 NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase increases expression ISO efavirenz results in increased expression of OPA1 mRNA CTD PMID:28940366 NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma decreases expression ISO efavirenz results in decreased expression of PPARG mRNA CTD PMID:21619898 NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
JBrowse link
G Rmdn3 regulator of microtubule dynamics 3 increases expression ISO efavirenz results in increased expression of RMDN3 protein CTD PMID:28940366 NCBI chr 3:106,125,961...106,146,568
Ensembl chr 3:106,125,951...106,146,586
JBrowse link
G Serpine1 serpin family E member 1 increases secretion ISO efavirenz results in increased secretion of SERPINE1 protein CTD PMID:21619898 NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
JBrowse link
G Slc5a5 solute carrier family 5 member 5 multiple interactions ISO [efavirenz co-treated with TSHB protein] results in increased expression of SLC5A5 mRNA; [efavirenz co-treated with TSHB protein] results in increased expression of SLC5A5 protein CTD PMID:16030158 NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 decreases expression ISO efavirenz results in decreased expression of SREBF1 mRNA CTD PMID:21619898 NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
JBrowse link
G Tg thyroglobulin increases expression ISO efavirenz results in increased expression of TG mRNA; efavirenz results in increased expression of TG protein CTD PMID:16030158 NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
JBrowse link
G Tpo thyroid peroxidase increases expression ISO efavirenz results in increased expression of TPO mRNA; efavirenz results in increased expression of TPO protein CTD PMID:16030158 NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
JBrowse link
G Tshb thyroid stimulating hormone subunit beta multiple interactions ISO [efavirenz co-treated with TSHB protein] results in increased expression of SLC5A5 mRNA; [efavirenz co-treated with TSHB protein] results in increased expression of SLC5A5 protein; efavirenz promotes the reaction [TSHB protein affects the abundance of Iodine]; sodium perchlorate inhibits the reaction [efavirenz promotes the reaction [TSHB protein affects the abundance of Iodine]] CTD PMID:16030158 NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
JBrowse link
G Tshr thyroid stimulating hormone receptor increases expression ISO efavirenz results in increased expression of TSHR mRNA CTD PMID:16030158 NCBI chr 6:110,341,585...110,475,297
Ensembl chr 6:110,341,581...110,474,538
JBrowse link
G Vdac1 voltage-dependent anion channel 1 multiple interactions ISO efavirenz promotes the reaction [VDAC1 protein binds to HSPA9 protein] CTD PMID:28940366 NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
JBrowse link
olodaterol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adrb2 adrenoceptor beta 2 multiple interactions
affects expression
increases expression
ISO Cycloheximide inhibits the reaction [olodaterol affects the expression of ADRB2 mRNA]; EDN1 protein promotes the reaction [olodaterol results in increased expression of ADRB2 mRNA]; ICI 118551 inhibits the reaction [olodaterol affects the expression of ADRB2 mRNA]; olodaterol promotes the reaction [EDN1 protein results in increased expression of ADRB2 mRNA] CTD PMID:22483689 PMID:24705868 NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
JBrowse link
G Edn1 endothelin 1 multiple interactions
decreases expression
ISO 2'-O-methyl-8-(4-chlorophenylthio)cAMP inhibits the reaction [olodaterol results in decreased expression of EDN1 mRNA]; EDN1 protein promotes the reaction [olodaterol results in increased expression of ADRB2 mRNA]; ICI 118551 inhibits the reaction [olodaterol results in decreased expression of EDN1 mRNA]; N(6)-benzyl-cyclic adenosine 5'-monophosphate inhibits the reaction [olodaterol results in decreased expression of EDN1 mRNA]; olodaterol inhibits the reaction [Oxotremorine results in increased expression of EDN1 mRNA]; olodaterol inhibits the reaction [TGFB1 protein results in increased expression of EDN1 mRNA]; olodaterol promotes the reaction [EDN1 protein results in increased expression of ADRB2 mRNA] CTD PMID:22483689 PMID:22796455 NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO olodaterol inhibits the reaction [TGFB1 protein results in increased expression of EDN1 mRNA] CTD PMID:22796455 NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 20089
    chemical entity 20088
      atom 20058
        nonmetal atom 19979
          nitrogen atom 18963
            nitrogen molecular entity 18937
              organonitrogen compound 18736
                organonitrogen heterocyclic compound 17766
                  benzoxazine 195
                    (2S)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-4-(3-methoxypropyl)-2-methyl-2H-1,4-benzoxazin-3(4H)-one 0
                    (2S)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-4-(3-methoxypropyl)-2H-1,4-benzoxazin-3(4H)-one 0
                    (R)-2,7-Dihydroxy-2H-1,4-benzoxazin-3(4H)-one 0
                    1'-[2-[4-(trifluoromethyl)phenyl]ethyl]-2-spiro[1H-3,1-benzoxazine-4,4'-piperidine]one 0
                    1-methyl-7-nitroisatoic anhydride 0
                    2,4-Dihydroxy-6,7-dimethoxy-2H-1,4-benzoxazin-3(4H)-one 0
                    2-(2,3,4-trimethoxyphenyl)-2,3-dihydro-1,3-benzoxazin-4-one 0
                    2-(2-ethyl-6-methyl-3-oxo-1,4-benzoxazin-4-yl)-N-[(5-methyl-2-furanyl)methyl]-N-(3-pyridinylmethyl)acetamide 0
                    2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)-N-(thiophen-2-ylmethyl)acetamide 0
                    2-(3-nitrophenyl)-3,1-benzoxazin-4-one 0
                    2-(3-thiophenyl)acetic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester 0
                    2-(5-bromo-2-furanyl)-6-methyl-3,1-benzoxazin-4-one 0
                    2-(tert-butyl)-6,7-dimethoxy-4H-3,1-benzoxazin-4-one 0
                    2-Hydroxy-4,7-dimethoxy-2H-1,4-benzoxazin-3(4H)-one 0
                    2-Hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one 0
                    2-[2,2-dimethyl-6-[4-morpholinyl(oxo)methyl]-3-oxo-1,4-benzoxazin-4-yl]-N-phenylacetamide 0
                    2-[4-[(4-chlorophenyl)-oxomethyl]-2,3-dihydro-1,4-benzoxazin-3-yl]acetic acid methyl ester 0
                    2-hydroxy-2-phenyl-3H-1,3-benzoxazin-4-one 0
                    2-methylidene-3-oxo-4a,7,8,8a-tetrahydro-4H-1,4-benzoxazine-7-carboxylic acid 0
                    3,4-Dihydro-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylate 0
                    3,4-Dihydro-7-hydroxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylate 0
                    3,4-dihydro-7-methoxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carbonyl-CoA 0
                    3,4-dihydro-7-methoxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylic acid 0
                    3-(2,6-dimethyl-3-oxo-1,4-benzoxazin-4-yl)-N-(thiophen-2-ylmethyl)propanamide 0
                    3-(2-oxopropyl)-1,4-benzoxazin-2-one 0
                    3-chloro-1-benzothiophene-2-carboxylic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester 0
                    3-methyl-N-[4-(4-oxo-3,1-benzoxazin-2-yl)phenyl]butanamide 0
                    3-phenyl-2H-1,4-benzoxazine 0
                    4-(6-chloro-2-methyl-2,3-dihydro-1,4-benzoxazin-4-yl)-4-oxo-N-(phenylmethyl)butanamide 0
                    4-(dimethylsulfamoyl)benzoic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester 0
                    4-[(3-oxo-4H-1,4-benzoxazin-7-yl)sulfonyl]-1-piperazinecarboxylic acid ethyl ester 0
                    4-[[(4-acetyl-2,3-dihydro-1,4-benzoxazin-7-yl)sulfonylamino]methyl]-N-(3-methylphenyl)-1-cyclohexanecarboxamide 0
                    6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-2,2-dimethyl-2H-1,4-benzoxazin-3(4H)-one 0
                    6-[1-oxo-2-[[4-(phenylmethyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]thio]ethyl]-4H-1,4-benzoxazin-3-one 0
                    6-[2-(2-methoxyphenyl)imino-3-(2-oxolanylmethyl)-4-thiazolyl]-4H-1,4-benzoxazin-3-one 0
                    6-[2-butylimino-3-(cyclopentylideneamino)-4-thiazolyl]-4H-1,4-benzoxazin-3-one 0
                    6-bromo-N-(3,4-dimethylphenyl)-3-oxo-4H-1,4-benzoxazine-7-sulfonamide 0
                    6-chloro-3-(3,3-dimethyl-2-oxobutyl)-1,4-benzoxazin-2-one 0
                    6-chloro-3-(4-methyl-2-oxopentyl)-1,4-benzoxazin-2-one 0
                    6-chloro-3-[2-(2-furanyl)-2-oxoethyl]-1,4-benzoxazin-2-one 0
                    6-chloro-N-(3,4-dimethylphenyl)-3-oxo-4H-1,4-benzoxazine-7-sulfonamide 0
                    6-hydroxy-2-(4-nitrophenyl)-3,1-benzoxazin-4-one 0
                    Avenalumin II 0
                    Avenalumin III 0
                    Azasetron hydrochloride 0
                    Benoxacor 152
                    C-1027 chromophore 0
                    DIBOA + 0
                    DIMBOA + 0
                    DIMBOA glucoside + 0
                    Dianthalexin 0
                    HBOA + 0
                    HMBOA beta-D-glucoside 0
                    LSM-11779 0
                    LSM-33653 0
                    LSM-33656 0
                    N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide 0
                    N-(3,5-dimethoxyphenyl)-6-methyl-3-oxo-4H-1,4-benzoxazine-7-sulfonamide 0
                    N-[(1S)-1-(1H-benzimidazol-2-yl)-2-\{4-[(5S)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl\}ethyl]-4-methyl-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide 0
                    N-[(4-fluorophenyl)methyl]-2-[3-oxo-6-(1-piperidinylsulfonyl)-1,4-benzoxazin-4-yl]acetamide 0
                    N-[(4-tert-butylphenyl)methyl]-3-oxo-4H-1,4-benzoxazine-6-carboxamide 0
                    N-[2-(\{2-amino-6-ethyl-5-[4-(3-methoxypropyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl]pyrimidin-4-yl\}amino)ethyl]naphthalene-2-sulfonamide 0
                    N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-2-(3-oxo-1,4-benzoxazin-4-yl)acetamide 0
                    N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-3-(3-oxo-1,4-benzoxazin-4-yl)propanamide 0
                    N-[4-(4-oxo-2,3-dihydro-1,3-benzoxazin-2-yl)phenyl]acetamide 0
                    N-\{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl]ethyl\}acetamide 0
                    N-butyl-4-[(4-methyl-3-oxo-1,4-benzoxazin-2-ylidene)methyl]benzamide 0
                    N-methylisatoic anhydride 0
                    TRIBOA + 0
                    TRIBOA beta-D-glucoside 0
                    acetic acid [2-(2-methylphenyl)-4-oxo-3,1-benzoxazin-7-yl] ester 0
                    acetic acid [3-oxo-2-(trifluoromethyl)-4H-1,4-benzoxazin-2-yl] ester 0
                    bentranil 0
                    caroxazone 0
                    carsalam 0
                    cetilistat 1
                    chlorthenoxazine 0
                    efavirenz 40
                    etifoxine 0
                    flumioxazin 0
                    olodaterol 3
                    platensimycin B2 0
                    trifludimoxazin 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 20089
    subatomic particle 20058
      composite particle 20058
        hadron 20088
          baryon 20088
            nucleon 20088
              atomic nucleus 20088
                atom 20058
                  main group element atom 19960
                    p-block element atom 19990
                      carbon group element atom 19916
                        carbon atom 19909
                          organic molecular entity 19909
                            organic molecule 19856
                              organic cyclic compound 19612
                                organic heterocyclic compound 18824
                                  organic heteropolycyclic compound 18298
                                    organic heterobicyclic compound 17170
                                      benzoxazine 195
                                        (2S)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-4-(3-methoxypropyl)-2-methyl-2H-1,4-benzoxazin-3(4H)-one 0
                                        (2S)-6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2-(3,5-difluorophenyl)-4-(3-methoxypropyl)-2H-1,4-benzoxazin-3(4H)-one 0
                                        (R)-2,7-Dihydroxy-2H-1,4-benzoxazin-3(4H)-one 0
                                        1'-[2-[4-(trifluoromethyl)phenyl]ethyl]-2-spiro[1H-3,1-benzoxazine-4,4'-piperidine]one 0
                                        1-methyl-7-nitroisatoic anhydride 0
                                        2,4-Dihydroxy-6,7-dimethoxy-2H-1,4-benzoxazin-3(4H)-one 0
                                        2-(2,3,4-trimethoxyphenyl)-2,3-dihydro-1,3-benzoxazin-4-one 0
                                        2-(2-ethyl-6-methyl-3-oxo-1,4-benzoxazin-4-yl)-N-[(5-methyl-2-furanyl)methyl]-N-(3-pyridinylmethyl)acetamide 0
                                        2-(2-methyl-3-oxo-1,4-benzoxazin-4-yl)-N-(thiophen-2-ylmethyl)acetamide 0
                                        2-(3-nitrophenyl)-3,1-benzoxazin-4-one 0
                                        2-(3-thiophenyl)acetic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester 0
                                        2-(5-bromo-2-furanyl)-6-methyl-3,1-benzoxazin-4-one 0
                                        2-(tert-butyl)-6,7-dimethoxy-4H-3,1-benzoxazin-4-one 0
                                        2-Hydroxy-4,7-dimethoxy-2H-1,4-benzoxazin-3(4H)-one 0
                                        2-Hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one 0
                                        2-[2,2-dimethyl-6-[4-morpholinyl(oxo)methyl]-3-oxo-1,4-benzoxazin-4-yl]-N-phenylacetamide 0
                                        2-[4-[(4-chlorophenyl)-oxomethyl]-2,3-dihydro-1,4-benzoxazin-3-yl]acetic acid methyl ester 0
                                        2-hydroxy-2-phenyl-3H-1,3-benzoxazin-4-one 0
                                        2-methylidene-3-oxo-4a,7,8,8a-tetrahydro-4H-1,4-benzoxazine-7-carboxylic acid 0
                                        3,4-Dihydro-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylate 0
                                        3,4-Dihydro-7-hydroxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylate 0
                                        3,4-dihydro-7-methoxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carbonyl-CoA 0
                                        3,4-dihydro-7-methoxy-2-methylene-3-oxo-2H-1,4-benzoxazine-5-carboxylic acid 0
                                        3-(2,6-dimethyl-3-oxo-1,4-benzoxazin-4-yl)-N-(thiophen-2-ylmethyl)propanamide 0
                                        3-(2-oxopropyl)-1,4-benzoxazin-2-one 0
                                        3-chloro-1-benzothiophene-2-carboxylic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester 0
                                        3-methyl-N-[4-(4-oxo-3,1-benzoxazin-2-yl)phenyl]butanamide 0
                                        3-phenyl-2H-1,4-benzoxazine 0
                                        4-(6-chloro-2-methyl-2,3-dihydro-1,4-benzoxazin-4-yl)-4-oxo-N-(phenylmethyl)butanamide 0
                                        4-(dimethylsulfamoyl)benzoic acid [2-oxo-2-(3-oxo-4H-1,4-benzoxazin-6-yl)ethyl] ester 0
                                        4-[(3-oxo-4H-1,4-benzoxazin-7-yl)sulfonyl]-1-piperazinecarboxylic acid ethyl ester 0
                                        4-[[(4-acetyl-2,3-dihydro-1,4-benzoxazin-7-yl)sulfonylamino]methyl]-N-(3-methylphenyl)-1-cyclohexanecarboxamide 0
                                        6-(2,4-diamino-6-ethylpyrimidin-5-yl)-4-(3-methoxypropyl)-2,2-dimethyl-2H-1,4-benzoxazin-3(4H)-one 0
                                        6-[1-oxo-2-[[4-(phenylmethyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]thio]ethyl]-4H-1,4-benzoxazin-3-one 0
                                        6-[2-(2-methoxyphenyl)imino-3-(2-oxolanylmethyl)-4-thiazolyl]-4H-1,4-benzoxazin-3-one 0
                                        6-[2-butylimino-3-(cyclopentylideneamino)-4-thiazolyl]-4H-1,4-benzoxazin-3-one 0
                                        6-bromo-N-(3,4-dimethylphenyl)-3-oxo-4H-1,4-benzoxazine-7-sulfonamide 0
                                        6-chloro-3-(3,3-dimethyl-2-oxobutyl)-1,4-benzoxazin-2-one 0
                                        6-chloro-3-(4-methyl-2-oxopentyl)-1,4-benzoxazin-2-one 0
                                        6-chloro-3-[2-(2-furanyl)-2-oxoethyl]-1,4-benzoxazin-2-one 0
                                        6-chloro-N-(3,4-dimethylphenyl)-3-oxo-4H-1,4-benzoxazine-7-sulfonamide 0
                                        6-hydroxy-2-(4-nitrophenyl)-3,1-benzoxazin-4-one 0
                                        Avenalumin II 0
                                        Avenalumin III 0
                                        Azasetron hydrochloride 0
                                        Benoxacor 152
                                        C-1027 chromophore 0
                                        DIBOA + 0
                                        DIMBOA + 0
                                        DIMBOA glucoside + 0
                                        Dianthalexin 0
                                        HBOA + 0
                                        HMBOA beta-D-glucoside 0
                                        LSM-11779 0
                                        LSM-33653 0
                                        LSM-33656 0
                                        N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide 0
                                        N-(3,5-dimethoxyphenyl)-6-methyl-3-oxo-4H-1,4-benzoxazine-7-sulfonamide 0
                                        N-[(1S)-1-(1H-benzimidazol-2-yl)-2-\{4-[(5S)-1,1-dioxido-3-oxo-1,2-thiazolidin-5-yl]phenyl\}ethyl]-4-methyl-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide 0
                                        N-[(4-fluorophenyl)methyl]-2-[3-oxo-6-(1-piperidinylsulfonyl)-1,4-benzoxazin-4-yl]acetamide 0
                                        N-[(4-tert-butylphenyl)methyl]-3-oxo-4H-1,4-benzoxazine-6-carboxamide 0
                                        N-[2-(\{2-amino-6-ethyl-5-[4-(3-methoxypropyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl]pyrimidin-4-yl\}amino)ethyl]naphthalene-2-sulfonamide 0
                                        N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-2-(3-oxo-1,4-benzoxazin-4-yl)acetamide 0
                                        N-[3-(3,4-dihydro-1H-isoquinolin-2-yl)propyl]-3-(3-oxo-1,4-benzoxazin-4-yl)propanamide 0
                                        N-[4-(4-oxo-2,3-dihydro-1,3-benzoxazin-2-yl)phenyl]acetamide 0
                                        N-\{2-[6-(2,4-diamino-6-ethylpyrimidin-5-yl)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl]ethyl\}acetamide 0
                                        N-butyl-4-[(4-methyl-3-oxo-1,4-benzoxazin-2-ylidene)methyl]benzamide 0
                                        N-methylisatoic anhydride 0
                                        TRIBOA + 0
                                        TRIBOA beta-D-glucoside 0
                                        acetic acid [2-(2-methylphenyl)-4-oxo-3,1-benzoxazin-7-yl] ester 0
                                        acetic acid [3-oxo-2-(trifluoromethyl)-4H-1,4-benzoxazin-2-yl] ester 0
                                        bentranil 0
                                        caroxazone 0
                                        carsalam 0
                                        cetilistat 1
                                        chlorthenoxazine 0
                                        efavirenz 40
                                        etifoxine 0
                                        flumioxazin 0
                                        olodaterol 3
                                        platensimycin B2 0
                                        trifludimoxazin 0
paths to the root